Human Cytomegalovirus (HCMV) Detection Kit (Fluorescence PCR)

Epidemiology

Human cytomegalovirus (HCMV) possesses the largest genome among herpesviruses, encoding over 200 proteins. Its host range is strictly limited to humans, and no animal model for infection currently exists. The virus replicates slowly over an extended cycle, forming intranuclear inclusion bodies and inducing perinuclear and cytoplasmic inclusions accompanied by cellular swelling (cytomegaly), which gives the virus its name. Genomic and phenotypic diversity allows classification into multiple strains, but antigenic differences between them lack clinical significance.

HCMV causes systemic infections that can involve many organs. Clinical manifestations are often silent yet diverse and complex; in some individuals, infection leads to conditions such as retinitis, hepatitis, pneumonitis, encephalitis, colitis, monocytosis, and thrombocytopenic purpura. The virus is distributed globally, with seroprevalence rates of 45–50% in industrialized nations and over 90% in developing regions. HCMV can persist in a latent state and reactivate during immunosuppression, particularly in leukemia and transplant recipients, potentially resulting in graft necrosis and life-threatening disease. Congenital infection, transmitted in utero, may cause stillbirth, miscarriage, preterm delivery, and developmental anomalies, thereby impacting perinatal health and population quality.

Work Flow

For sample preparation, nucleic acid extraction can be carried out with an automatic extractor or by hand. The procedure should be performed according to the selected extraction kit’s instructions. Using 200 µL of patient material, the recommended elution volume is 80 µL for certain protocols.

An appropriate commercial extraction kit, such as a silica spin-column or magnetic bead-based system, may be employed. With these reagents, a sample input of 200 µL and an elution volume of 100 µL is generally advised. Always consult the manufacturer’s protocol for exact details.